To begin with, despite the conclusion that aberrant IGF2BP3 expression was associated with immune cell infiltration and prognosis of human cancers, we cannot definitively ascertain whether IGF2BP3 may exert functional effects on patient survival via an immune response. The gene discussed is IGF2BP3; the disease is cancer.